Literature DB >> 9058777

Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis.

N Tanuma1, T Kojima, T Shin, Y Aikawa, T Kohji, Y Ishihara, Y Matsumoto.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory disease of the central nervous system that can be induced by immunization with myelin basic protein (MBP)/complete Freund's adjuvant and serves as a model for multiple sclerosis. Recent studies have suggested that cytokines play a crucial role in the clinical course of EAE. To clarify the roles of cytokines in EAE, we examined levels of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta1 (TGF-beta1) and interleukin-10 (IL-10) mRNA in isolates from infiltrating inflammatory cells in EAE lesions induced in Lewis rats. The non-radioactive and sensitive competitive PCR method was employed to quantify the relative amounts of cytokine mRNA. Levels of both IFN-gamma and TNF-alpha mRNA were increased at the early stage of EAE and rapidly decreased at the peak stage. On the other hand, TGF-beta1 mRNA was demonstrated throughout the course of EAE as well as under normal conditions and its amount paralleled the severity of EAE. IL-10 mRNA was detected by reverse transcription polymerase chain reaction (RT-PCR) under normal conditions, but was below the level of detection of competitive PCR. IL-10 mRNA expression peaked at the early stage of EAE and declined gradually thereafter. Taken together, these results suggest that IFN-gamma and TNF-alpha might play a crucial role in the development of EAE. Furthermore, it appears that the peak expression of IL-10 mRNA at the early stage and the following marked TGF-beta1 expression at the peak stage might represent an important endogenous mechanism to limit the extent of inflammation and to prevent relapse in the course of acute monophasic EAE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058777     DOI: 10.1016/s0165-5728(96)00199-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Authors:  B Bourrié; E Bribes; M Esclangon; L Garcia; J Marchand; C Thomas; J P Maffrand; P Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.

Authors:  R Aharoni; D Teitelbaum; O Leitner; A Meshorer; M Sela; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  A chronically implantable, hybrid cannula-electrode device for assessing the effects of molecules on electrophysiological signals in freely behaving animals.

Authors:  Bradley Greger; Babak Kateb; Peter Gruen; Paul H Patterson
Journal:  J Neurosci Methods       Date:  2007-04-05       Impact factor: 2.390

4.  Evaluation of oxidative stress and inflammation in long term Brucella melitensis infection.

Authors:  Ismet M Melek; Suat Erdogan; Sefa Celik; Ozkan Aslantas; Taskin Duman
Journal:  Mol Cell Biochem       Date:  2006-06-30       Impact factor: 3.396

5.  Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis.

Authors:  G C Suvannavejh; M C Dal Canto; L A Matis; S D Miller
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.

Authors:  B Serafini; S Columba-Cabezas; F Di Rosa; F Aloisi
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 7.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

8.  Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.

Authors:  Yan Shen; Wei Xu; Yi-Wei Chu; Ying Wang; Quan-Sheng Liu; Si-Dong Xiong
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expression.

Authors:  Mary E Hamby; James A Hewett; Sandra J Hewett
Journal:  Glia       Date:  2010-08-15       Impact factor: 7.452

10.  Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats.

Authors:  Sefa Celik; Suat Erdogan
Journal:  Mol Cell Biochem       Date:  2008-02-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.